This document provides an overview of computer validation and compliance with regulatory guidance. It discusses the need for computer validation and outlines key principles from guidance documents such as software validation, use of off-the-shelf software in medical devices, and validation of electronic records and signatures. Validation approaches for different systems and software are covered, including spreadsheets. The document provides references to FDA and international regulatory guidance on these topics.
Overview of computer validation processes, including guidance documents and the importance of validation.
Discussion on various systems like LIMS, HPLC, their significance in clinical trials, and relevant guidance dates.
Details the types of software in medical devices and FDA-compliant validation processes.
Highlights stages of software validation including planning, testing, and documentation for FDA submissions.
Requirements of 21 CFR Part 11 for electronic records, validation, and audit trails.
Guidance on standards for validation, testing procedures, and auditing necessary for clinical trial systems.Importance of validating spreadsheets in clinical trials and history of electronic spreadsheet tools.
Questions around the necessity, coordination, and budgeting of validation efforts, plus ERP system insights.
References to key FDA guidance and regulations pertaining to software validation and electronic records.
Why ComputerValidation ?
List of Guidance Documents.
General Principles of Software Validation.
OTS Software Use in Medical Devices.
Electronic Records, Electronic Signatures ( 21 CFR Part 11 )
Guidance Document for Computerized System used in Clinical Trials.
Validation of Electronic Spreadsheet.
Introduction to Validation Master Plan.
Definition of ERP System
Possible Questions
References
www.PharmInfopedia.com
Data and InformationManagement Systems
Problem Solving Applications
Communication Aids ( e- MAIL, DIMS )
Laboratory Automation ( LIMS, HPLC, DISSOLUTION,
MICROBALANCES )
Process Control
Computerised System used for Clinical Trials and Manufacturing of
Medical Devices
www.PharmInfopedia.com
5.
April 1999 ComputerizedSystems Used in
Clinical Trials
September 1999 Off-The-Shelf Software Use in
Medical Devices
August 2001 Electronic Records; Electronic
Signatures – Validation
January 2002 General Principles of Software
Validation
August 2003 Electronic Records; Electronic
Signatures - Scope and
Application
21 CFR Part 11 Electronic Records; Electronic
Signatures
21 CFR Part 820 Quality System Regulation
www.PharmInfopedia.com
6.
Software used asa component, part, or accessory of a
medical device
Software that is itself a medical device
Software used in the production of a device
Software used in implementation of the device
manufacturer's quality system
January 11, 2002,
CDRH, CBER www.PharmInfopedia.com
7.
Least Burdernsome andSpecific Approach
SOFTWARE
VALIDATION
Validation during each activity of
life cycle model
21 CFR Part 820
OTS Software Validation
(device manufacturer
responsible)
Simulated Use Environment and
User Site Testing
Overall design validation for the system
Validation Coverage / Extent of Validation
Validation Documentation
Self-Validation not followed
Validation Master Plan
Premarket Submission to :
ODE
CDRH
CBER
Postchange Software Validation
Documentation Updation
www.PharmInfopedia.com
8.
Quality Planning
System RequirementsDefinition
Detailed Software Requirements Specification
Software Design Specification
Construction or Coding
Testing
Installation
Operation and Support
Maintenance
Retirement
www.PharmInfopedia.com
9.
Guidance for premarketsubmission to FDA
3 Level of Concerns
Documentation ( Basic and Special)
Corneal Topographer (Minor Level of Concern Device)
Implantable Medical Device Programmers (Major Level of Concern
Device)
September 9, 1999www.PharmInfopedia.com
21
C
F
R
P
A
R
T
11
Was issuedin March 1997
Records in electronic form that are created,
modified, maintained, archived, retrieved, or transmitted
Submission to FDA and also to comply with Predicate Rules
(The Act ,The PHS Act)
Three major concerns demanded the revision of 21 CFR Part 11
1. unnecessarily restrict the use of electronic technology
2. significantly increase the costs of compliance
3. discourage innovation and technological advances
Revised and issued in August 2003
www.PharmInfopedia.com
Records maintained inelectronic format in place of paper format
(PredicateRules and FDA)
No predicate rule requirement but it is in electronic format --- No CFR Part 11
Records maintained in electronic format in addition to paper format
(Predicate Rules and FDA)
Records maintained in electronic format
(Predicate Rules, but not required by FDA)
Electronic Record used for generating submission if not required by Predicate
Rules is not a part of CFR Part 11 and vice versa
Electronic signatures that are intended to be the equivalent of handwritten
signatures, initials, and other general signings (Predicate Rules)
www.PharmInfopedia.com
System Requirements Specifications
Documentationof Validation Activity
Dynamic Testing
Static Verification Techniques
Extent of Validation
Independence of Review
Revalidation
www.PharmInfopedia.com
16.
Documentation of userrequirements/intended
use
Computer system implements needs correctly
Documentation of Validation Activity
Validation Plan
Validation Procedure
Validation Report
www.PharmInfopedia.com
17.
Key testing consideration
TestingCondition
Normal
Stress
Actual Performance Testing
Simulation Test
User-Site Test
Software testing
Structural Testing (White Box Testing)
Functional Testing (Black Box Testing)
Program Build Testing
www.PharmInfopedia.com
Third Party
Person ofthe Organisation
Revalidation
As per requirement of user
By system upgradation
During routine servicing and maintenance
Network like internet
www.PharmInfopedia.com
20.
IS IT NECESSARYTO VALIDATE COMPUTERIZED
SYSTEMS USED IN CLINICAL TRIALS
April 1999 USFDA
www.PharmInfopedia.com
21.
Automating analyticaldata calculations from various laboratory
analyses
Tracking and summarizing product complaints
Gathering and summarizing clinical trial data collection and
analyses
Validation of Electronic Spreadsheet is necessary in order to
evaluate key drivers : Authenticity, Data and System Integrity, and
Confidentiality
Should comply with Predicate Regulations
21 CFR Part 11
www.PharmInfopedia.com
22.
ELECTRONIC
SPREADSHEET
YEAR OF DEBUTLAUNCHER
VisiCalc 1978 Harvad Business School
Lotus 1-2-3 1983 IBM
Excel 1984 Microsoft Corporation
www.PharmInfopedia.com
23.
Preparation of testcases/test procedures for each functional
element defined. Test case must challenge the operation and
performance of the system especially for its most critical
parameters
Execution of the test cases and the results must be recorded
Evaluate whether software has been validated for its intended
use
Documented evidence of all testing procedures, test input data,
and test results must be retained
www.PharmInfopedia.com
24.
"HOW MUCH VALIDATIONIS ENOUGH ?"
"WHICH SYSTEMS DO WE HAVE TO VALIDATE ?“
“HOW TO COORDINATE THE VALIDATION EFFORTS ?”
“HOW TO MAKE VALIDATION EFFORT WITHIN THE
BUDGET ?”
www.PharmInfopedia.com
25.
Integrates planning,manufacturing, distribution, shipping, and
accounting into a single system
Designed to serve the needs of each different department within the
enterprise
Creates supply chain management
An ERP implementation can cost millions of dollars to create, and may
take several years to complete
Implement ERP in a more incremental fashion
Tremendous advantages:
1. Share information
2. Workflow becomes more automated
3. It can speed up the manufacturing process by automating
processes and workflow
4. It also reduces the need to carry large inventories.www.PharmInfopedia.com
26.
According toyour view point, Why it is necessary to validate
“Computer” ? [ 2 marks ]
State the general principles of Software Validation. [ 5 marks ]
What is OTS Software ? How the level of concern affect the
documentation of OTS software validation ? [ 2 marks ]
State the key principles of validating Electronic Records and Electronic
Signatures. [ 5 marks ]
How will you validate the Electronic Spreadsheet ? [ 2 marks ]
www.PharmInfopedia.com
27.
General Principles ofSoftware Validation; Final Guidance for Industry and
FDA Staff, January 11, 2002.
(http://www.fda.gov/cdrh/comp/guidance/938.html)
Guidance for Industry, FDA Reviewers and Compliance on Off-The-Shelf
Software Use in Medical Devices, September 9, 1999.
(http://www.fda.gov/cdrh/ode/guidance/585.html)
Guidance for IndustryPart 11, Electronic Records; Electronic Signatures –
Scope and Application, August 2003.
(http://www.fda.gov/cder/guidance/5667fnl.htm)
Guidance for Industry 21 CFR Part 11; Electronic Records; Electronic Signatures
Validation, August 2001.
(http://www.fda.gov/ohrms/dockets/98fr/001538gd.pdf)
Guidance for Industry, Computerized Systems used in Clinical Trials, April
1999.
(http://www.fda.gov/ora/compliance_ref/bimo/ffinalcct.htm)www.PharmInfopedia.com
28.
US Food andDrug Administration, Center for Devices and Radiological
Health, Code of Federal Regulations, Title 21, Part 11, Volume 1, Electronic
Records and Electronic Signatures, Revised as of April 1, 2005
(http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?
CFRPart=11&showFR=1)
Computer Validation Guide, Final Draft, Version 2, December 2002.
(http://apic.cefic.org/pub/compvalfinaldraftDecember2002.pdf)
Technical Considerations for the Validation of Electronic Spreadsheets or
Complying with 21 CFR Part 11 by Taun T. Phan, Pharmaceutical Technology,
January 2003.
(www.pharmtech.com)
Computer Validation Master Planning “Validation Strategies” by Michael
Schousboe, Pharmaceutical Technology, November 1, 2005.
(www.pharmtech.com)
Computers in Pharmaceutical Technology, Encyclopedia of Pharmaceutical
Technology, Volume 3.
www.PharmInfopedia.com